Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) President & CEO To Ring The NASDAQ Stock Market Opening Bell

NEW YORK, April 26 /PRNewswire-FirstCall/ -- The following is being issued by NASDAQ :

What:

Deborah Dunsire, M.D. President & CEO of Millennium Pharmaceuticals will preside over the opening bell to celebrate its 10 year anniversary on the NASDAQ.

Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Thursday April 27th, 2006 at 9:30 a.m. EDT Contacts: Theresa McNeely Corporate Communications 617.679.7405 theresa.mcneely@mpi.com NASDAQ MarketSite: Stephanie Lowenthal; 646.441.5220 Feed Information:

The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA-5 C-band/transponder 14. The downlink frequency is 3980 horizontal; audio: 6.2/6.8. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Stephanie Lowenthal at (646) 441-5220.

Photos:

To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About Millennium Pharmaceuticals (MLNM):

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company’s research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company’s website is http://www.millennium.com.

NASDAQ

CONTACT: Theresa McNeely, Corporate Communications of MillenniumPharmaceuticals, Inc., +1-617-679-7405, theresa.mcneely@mpi.com orStephanie Lowenthal of NASDAQ MarketSite, +1-646-441-5220

MORE ON THIS TOPIC